 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
| «1234 |
- | Eucrisa (crisaborole) / Pfizer
Trial completion date, Trial initiation date, Trial primary completion date: Steroid-reducing Effects of Crisaborole (clinicaltrials.gov) - Aug 6, 2019
P4, N=60, Recruiting, Sponsor: Johns Hopkins University
Trial completion date: Sep 2020 --> Dec 2020 | Initiation date: Jul 2019 --> Oct 2019 | Trial primary completion date: Jun 2020 --> Sep 2020
- | triamcinolone acetonide topical / Generic mfg.
Biomarker, Trial completion date, Trial initiation date, Trial primary completion date: The Efficacy of Topical Sesame Oil Versus Topical Triamcinolone on Oral Lichen Planus and Salivary Level of Oxidative Stress Biomarker [MDA] (clinicaltrials.gov) - Aug 1, 2019
P1, N=40, Not yet recruiting, Sponsor: Mona Taha Mohammed MD
Trial completion date: Sep 2020 --> Dec 2020 | Initiation date: Jul 2019 --> Oct 2019 | Trial primary completion date: Jun 2020 --> Sep 2020 Trial completion date: Dec 2019 --> Dec 2020 | Initiation date: Dec 2018 --> Dec 2019 | Trial primary completion date: Nov 2019 --> Nov 2020
- |||||| Eucrisa (crisaborole) / Pfizer
New trial: Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period (clinicaltrials.gov) - Jul 5, 2019
P, N=16, Recruiting, Sponsor: Clinical Research Center of the Carolinas
- || Eucrisa (crisaborole) / Pfizer
Trial completion date, Trial initiation date, Trial primary completion date: Steroid-reducing Effects of Crisaborole (clinicaltrials.gov) - May 15, 2019
P4, N=60, Recruiting, Sponsor: Johns Hopkins University
Trial completion date: Dec 2019 --> Dec 2020 | Initiation date: Dec 2018 --> Dec 2019 | Trial primary completion date: Nov 2019 --> Nov 2020 Trial completion date: Jun 2020 --> Sep 2020 | Initiation date: Apr 2019 --> Jul 2019 | Trial primary completion date: Mar 2020 --> Jun 2020
- | Valchlor (mechlorethamine gel) / Helsinn, Recordati
Trial completion date: MIDAS: Mechlorethamine Induced Contact Dermatitis Avoidance Study (clinicaltrials.gov) - Apr 2, 2019
P2, N=28, Recruiting, Sponsor: Rochester Skin Lymphoma Medical Group, PLLC
Trial completion date: Jun 2020 --> Sep 2020 | Initiation date: Apr 2019 --> Jul 2019 | Trial primary completion date: Mar 2020 --> Jun 2020 Trial completion date: Dec 2019 --> Dec 2020
- |||| Eucrisa (crisaborole) / Pfizer
New P4 trial: Steroid-reducing Effects of Crisaborole (clinicaltrials.gov) - Feb 6, 2019
P4, N=60, Recruiting, Sponsor: Johns Hopkins University
- | triamcinolone acetonide topical / Generic mfg.
Biomarker, Trial termination, Biopsy: GNE-AD: A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal (clinicaltrials.gov) - Jan 24, 2019
P4, N=11, Terminated, Sponsor: University of California, San Francisco
Trial completion date: Dec 2019 --> Dec 2020 Completed --> Terminated; Unable to meet the study's recruitment goals
- | triamcinolone acetonide topical / Generic mfg.
New P1 trial: Evaluation of Topical Chamomile Versus Topical Triamcinolone Acetonide in Management of Oral Lichen Planus (clinicaltrials.gov) - Jan 4, 2019
P1, N=37, Not yet recruiting, Sponsor: Cairo University
- | triamcinolone acetonide topical / Generic mfg.
Trial completion date, Trial primary completion date: Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease (clinicaltrials.gov) - Dec 31, 2018
P=N/A, N=38, Not yet recruiting, Sponsor: Cairo University
Completed --> Terminated; Unable to meet the study's recruitment goals Trial completion date: Dec 2019 --> Jan 2019 | Trial primary completion date: Dec 2019 --> Jan 2019
- | triamcinolone acetonide topical / Generic mfg.
New trial: Diode Laser Versus Topical Corticosteroids in Management of Oral Ulcers in Behcet's Disease (clinicaltrials.gov) - Dec 11, 2018
P=N/A, N=38, Not yet recruiting, Sponsor: Cairo University
- | triamcinolone acetonide topical / Generic mfg.
Biomarker, New P1 trial: The Efficacy of Topical Sesame Oil Versus Topical Triamcinolone on Oral Lichen Planus and Salivary Level of Oxidative Stress Biomarker [MDA] (clinicaltrials.gov) - Nov 13, 2018
P1, N=40, Not yet recruiting, Sponsor: Mona Taha Mohammed MD
- | triamcinolone acetonide topical / Generic mfg.
Trial completion: Topical Steroid Formulation and Wet Wraps (clinicaltrials.gov) - Sep 13, 2018
P4, N=40, Completed, Sponsor: Seton Healthcare Family
Trial completion date: Dec 2019 --> Jan 2019 | Trial primary completion date: Dec 2019 --> Jan 2019 Active, not recruiting --> Completed
- | triamcinolone acetonide topical / Generic mfg.
Enrollment change, Trial withdrawal: DIPSO: Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis (clinicaltrials.gov) - Jul 19, 2018
P4, N=0, Withdrawn, Sponsor: University of Zurich
Active, not recruiting --> Completed N=88 --> 0 | Suspended --> Withdrawn
- | triamcinolone acetonide topical / Generic mfg.
Phase classification: Treatment of Early Nasal Polyposis With Topical Triamcinolone (clinicaltrials.gov) - Jun 28, 2018
P1/2, N=1, Terminated, Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.
N=88 --> 0 | Suspended --> Withdrawn Phase classification: P2 --> P1/2
- | triamcinolone acetonide topical / Generic mfg.
New P4 trial: Management of Pain in Oral Lichen Planus (clinicaltrials.gov) - Jun 28, 2018
P4, N=24, Completed, Sponsor: Sherine Adel Nasry
- |||| Opzelura (ruxolitinib cream) / Incyte, Maruho
Trial completion: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis (clinicaltrials.gov) - Apr 26, 2018
P2, N=307, Completed, Sponsor: Incyte Corporation
Phase classification: P2 --> P1/2 Active, not recruiting --> Completed
- | triamcinolone acetonide topical / Generic mfg.
Trial completion date: Topical Steroid Formulation and Wet Wraps (clinicaltrials.gov) - Apr 20, 2018
P4, N=40, Active, not recruiting, Sponsor: Seton Healthcare Family
Active, not recruiting --> Completed Trial completion date: Dec 2017 --> Jun 2018
- | Valchlor (mechlorethamine gel) / Helsinn, Recordati
New P2 trial: MIDAS: Mechlorethamine Induced Contact Dermatitis Avoidance Study (clinicaltrials.gov) - Dec 20, 2017
P2, N=28, Recruiting, Sponsor: Rochester Skin Lymphoma Medical Group, PLLC
- ||| Opzelura (ruxolitinib cream) / Incyte, Maruho
Enrollment closed: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis (clinicaltrials.gov) - Dec 11, 2017
P2, N=307, Active, not recruiting, Sponsor: Incyte Corporation
Trial completion date: Dec 2017 --> Jun 2018 Recruiting --> Active, not recruiting
- | triamcinolone acetonide topical / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - Nov 1, 2017
P=N/A, N=0, Withdrawn, Sponsor: Wake Forest University
Recruiting --> Active, not recruiting N=40 --> 0 | Active, not recruiting --> Withdrawn | Trial primary completion date: Oct 2017 --> Oct 2014
- | triamcinolone acetonide topical / Generic mfg.
Enrollment closed, Enrollment change: Topical Steroid Formulation and Wet Wraps (clinicaltrials.gov) - Oct 18, 2017
P4, N=40, Active, not recruiting, Sponsor: Seton Healthcare Family
N=40 --> 0 | Active, not recruiting --> Withdrawn | Trial primary completion date: Oct 2017 --> Oct 2014 Recruiting --> Active, not recruiting | N=75 --> 40
- |||||| triamcinolone acetonide topical / Generic mfg., pirfenidone / Generic mfg.
Enrollment open, Trial primary completion date: LADISLAO: Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars (clinicaltrials.gov) - Jul 17, 2017
P3, N=102, Recruiting, Sponsor: Centro Dermatológico Dr. Ladislao de la Pascua
Recruiting --> Active, not recruiting | N=75 --> 40 Not yet recruiting --> Recruiting | Trial primary completion date: Jan 2018 --> Dec 2019
- | triamcinolone acetonide topical / Generic mfg.
Biomarker, Trial completion, Enrollment change, Trial primary completion date, IO biomarker, Biopsy: GNE-AD: A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal (clinicaltrials.gov) - Apr 12, 2017
P4, N=11, Completed, Sponsor: University of California, San Francisco
Not yet recruiting --> Recruiting | Trial primary completion date: Jan 2018 --> Dec 2019 Recruiting --> Completed | N=15 --> 11 | Trial primary completion date: Jan 2017 --> Apr 2017
- | triamcinolone acetonide topical / Generic mfg.
Trial primary completion date, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - Mar 13, 2017
P=N/A, N=40, Active, not recruiting, Sponsor: Wake Forest University
Recruiting --> Completed | N=15 --> 11 | Trial primary completion date: Jan 2017 --> Apr 2017 Trial primary completion date: Oct 2016 --> Oct 2017
- triamcinolone acetonide topical / Generic mfg.
Enrollment open, Trial primary completion date: Topical Steroid Formulation and Wet Wraps (clinicaltrials.gov) - Feb 9, 2017
P4, N=75, Recruiting, Sponsor: Seton Healthcare Family
Trial primary completion date: Oct 2016 --> Oct 2017 Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2016 --> Mar 2017
- ||||| Opzelura (ruxolitinib cream) / Incyte, Maruho
New P2 trial: A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis (clinicaltrials.gov) - Jan 5, 2017
P2, N=300, Recruiting, Sponsor: Incyte Corporation
- triamcinolone acetonide topical / Generic mfg.
Biomarker, Trial primary completion date, IO biomarker, Biopsy: GNE-AD: A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal (clinicaltrials.gov) - Oct 27, 2016
P4, N=15, Recruiting, Sponsor: University of California, San Francisco
Not yet recruiting --> Recruiting | Trial primary completion date: Sep 2016 --> Mar 2017 Trial primary completion date: Jun 2016 --> Jan 2017
- |||||||||| triamcinolone acetonide topical / Generic mfg., pirfenidone / Generic mfg.
New P3 trial: LADISLAO: Efficacy of Intralesional Triamcinolone and 8% Topical Pirfenidone for Treatment of Keloid Scars (clinicaltrials.gov) - Jul 6, 2016
P3, N=102, Not yet recruiting, Sponsor: Centro Dermatológico Dr. Ladislao de la Pascua
- triamcinolone acetonide topical / Generic mfg.
Trial primary completion date, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - May 6, 2016
P=N/A, N=40, Active, not recruiting, Sponsor: Wake Forest University
Trial primary completion date: Jun 2016 --> Jan 2017 Trial primary completion date: Jun 2016 --> Oct 2016
- | triamcinolone acetonide topical / Generic mfg.
New P4 trial: Topical Steroid Formulation and Wet Wraps (clinicaltrials.gov) - Feb 11, 2016
P4, N=75, Not yet recruiting, Sponsor: Seton Healthcare Family
- triamcinolone acetonide topical / Generic mfg.
Biomarker, Trial primary completion date, IO biomarker, Biopsy: GNE-AD: A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal (clinicaltrials.gov) - Jan 17, 2016
P4, N=15, Recruiting, Sponsor: University of California, San Francisco
Trial primary completion date: Jun 2016 --> Oct 2016 Trial primary completion date: Jun 2015 --> Jun 2016
- triamcinolone acetonide topical / Generic mfg.
Trial primary completion date, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - Dec 12, 2015
P=N/A, N=40, Active, not recruiting, Sponsor: Wake Forest University
Trial primary completion date: Jun 2015 --> Jun 2016 Trial primary completion date: Jun 2015 --> Jun 2016
- | triamcinolone acetonide topical / Generic mfg.
Trial suspension: DIPSO: Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis (clinicaltrials.gov) - Dec 12, 2015
P4, N=88, Suspended, Sponsor: University of Zurich
Trial primary completion date: Jun 2015 --> Jun 2016 Recruiting --> Suspended
- tacrolimus topical / Generic mfg.
Enrollment change, Trial termination: Tacrolimus Ointment in Oral Lichen Planus (clinicaltrials.gov) - Jul 17, 2015
P=N/A, N=28, Terminated, Sponsor: University of Oulu
Recruiting --> Suspended N=40 --> 28 | Recruiting --> Terminated; Lack of resources
- triamcinolone acetonide topical / Generic mfg.
Biomarker, New P4 trial, IO biomarker, Biopsy: GNE-AD: A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal (clinicaltrials.gov) - Dec 16, 2014
P4, N=15, Recruiting, Sponsor: University of California, San Francisco
- triamcinolone acetonide topical / Generic mfg.
Trial primary completion date, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - May 26, 2014
P=N/A, N=40, Active, not recruiting, Sponsor: Wake Forest School of Medicine
N=40 --> 28 | Recruiting --> Terminated; Lack of resources Trial primary completion date: Jun 2014 --> Jun 2015
- triamcinolone acetonide topical / Generic mfg.
Trial completion date, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - May 26, 2014
P=N/A, N=40, Active, not recruiting, Sponsor: Wake Forest School of Medicine
Trial primary completion date: Jun 2014 --> Jun 2015 Trial completion date: Jun 2014 --> Jun 2015
- triamcinolone acetonide topical / Generic mfg.
Enrollment closed, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - May 26, 2014
P=N/A, N=40, Active, not recruiting, Sponsor: Wake Forest School of Medicine
Trial completion date: Jun 2014 --> Jun 2015 Recruiting --> Active, not recruiting
- triamcinolone acetonide topical / Generic mfg.
Trial termination: Treatment of Early Nasal Polyposis With Topical Triamcinolone (clinicaltrials.gov) - Jan 1, 2014
P2, N=2, Terminated, Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.
Recruiting --> Active, not recruiting Recruiting --> Terminated; not enough particpants
- triamcinolone acetonide topical / Generic mfg.
Enrollment change: Treatment of Early Nasal Polyposis With Topical Triamcinolone (clinicaltrials.gov) - Jan 1, 2014
P2, N=2, Terminated, Sponsor: Steward St. Elizabeth's Medical Center of Boston, Inc.
Recruiting --> Terminated; not enough particpants N=100 --> 2
- Enrollment change: Hydrogel Patch for the Treatment of Eczema (clinicaltrials.gov) - Nov 21, 2013
P=N/A, N=23, Terminated, Sponsor: University of California, San Francisco
N=100 --> 2 N=30 --> 23
- triamcinolone acetonide topical / Generic mfg.
Enrollment closed: NdYag Laser for Acne Keloidalis Nuchae (clinicaltrials.gov) - Mar 26, 2013
P=N/A, N=20, Active, not recruiting, Sponsor: Henry Ford Health System
N=30 --> 23 Completed --> Active, not recruiting
- New P4 trial: Comparison of Efficacy of Intralesional Triamcinolone Injection and Clobetasol Propionate Ointment for Psoriatic Nails (clinicaltrials.gov) - Oct 8, 2012
P4, N=16, Completed, Sponsor: Mahidol University
- triamcinolone acetonide topical / Generic mfg.
Enrollment change: NdYag Laser for Acne Keloidalis Nuchae (clinicaltrials.gov) - Sep 3, 2012
P=N/A, N=20, Active, not recruiting, Sponsor: Henry Ford Health System
Completed --> Active, not recruiting N=30 --> 20
- |||| lidocaine topical / Generic mfg.
Enrollment open: Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome (clinicaltrials.gov) - Mar 4, 2012
P2, N=60, Recruiting, Sponsor: Injury Care Medical Center
N=30 --> 20 Not yet recruiting --> Recruiting
- ||||| lidocaine topical / Generic mfg.
New P2 trial: Pain Patch Versus Injections in the Treatment of Pain Associated With Shoulder Impingement Syndrome (clinicaltrials.gov) - Feb 22, 2012
P2, N=60, Recruiting, Sponsor: Injury Care Medical Center
- Trial termination: Hydrogel Patch for the Treatment of Eczema (clinicaltrials.gov) - Oct 11, 2011
P=N/A, N=23, Terminated, Sponsor: University of California, San Francisco
Not yet recruiting --> Recruiting Recruiting --> Terminated; Loss of Funding
- | triamcinolone acetonide topical / Generic mfg.
New P4 trial: DIPSO: Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis (clinicaltrials.gov) - Sep 5, 2011
P4, N=88, Recruiting, Sponsor: University of Zurich